Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10

Aujourd'hui

02:22
Calliditas Therapeutics AB (publ) ("Calliditas") today announced that post-hoc results from its clinical Phase 2b study NEFIGAN will be presented in an oral session at the International IgA Nephropathy Network meeting (IIgANN) in Buenos Aires,...

01:56
Elekta (EKTA-B.ST) today announced that The Royal Marsden and The Institute of Cancer Research (ICR), London, have clinically implemented Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system that ushers radiotherapy into...

01:03
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients, today announced the independent Data Monitoring Committee (DMC) completed its pre-planned safety review of the first 200 patients enrolled in the...


24 septembre 2018

21:00
Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has granted marketing approval for BLINCYTO® (blinatumomab) for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). BLINCYTO was developed...

20:02
Med-X, Inc.'s ("Med-X") green pesticide product division, Nature-Cide, announced today that it has signed a direct distribution deal with one of the nation's leading green-focused pest control service companies, Pestmaster Services. Pestmaster...

19:01
The physical uptake of pharmaceutical cannabinoids when inhaled through Senzer's unique respiratory device is more than 50 times faster than oral delivery, at just a fraction of the dose, according to data released today under a clinical trial...

16:46
The results are from Cohort B of the Phase I/II Study in patients with relapsed Small Cell Lung Cancer (SCLC). This study preceded the Phase III ATLANTIS study with the same doses and a similar population  The poster has been presented at the...

16:01
Arena Pharmaceuticals, Inc. today announced positive topline results from its Phase 2a trial of olorinab, an investigational, peripherally restricted, highly selective, full agonist of the cannabinoid receptor 2 (CB2) in development for the...

14:02
BioCardia®, Inc. , a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that positive data from two studies of its investigational CardiAMP stem cell therapy were presented today at the...

13:09
The U.S. Food and Drug Administration today announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of medical products for patients with rare diseases....

10:30
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that updated phase 1 safety and efficacy data for [fam-] trastuzumab deruxtecan (DS-8201), an investigational HER2 targeting antibody drug conjugate (ADC), were presented for a...

10:03
Today, BIOTRONIK announced two-year data from the BIOFLOW-V randomized trial comparing the Orsiroa and Xienceb drug-eluting stents (DES). The data shows statistically improved outcomes for patients treated with Orsiro across a range of clinical...

09:22
BioElectron Technology Corporation (BioElectron), a clinical-stage platform biotechnology company, today announced positive results from its recently completed phase 2a clinical trial of EPI-589 in patients with Amyotrophic Lateral Sclerosis (ALS)....

09:00
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the...

09:00
Epic Sciences, in partnership with Memorial Sloan Kettering (MSK), have demonstrated that a liquid biopsy blood test may be used in clinical trials to find patients who are likely to benefit from PSMA-targeted therapies, before treatment is...

08:30
Theravance Biopharma, Inc. ("Theravance Biopharma") today highlighted that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion supporting the use of Trelegy Ellipta (fluticasone...

08:00
PolarityTE, Inc. today announced that SkinTEtm clinical results will be presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery The Meeting and the International Society of Plastic Regenerative Surgeons (ISPRES) Congress, both...

08:00
Audentes Therapeutics, Inc. , a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, today announced that new interim data from ASPIRO, the...

08:00
Eiger BioPharmaceuticals, Inc. , focused on the development and commercialization of targeted therapies for rare diseases, today announced the receipt of written guidance from the FDA, confirming concurrence on a pivotal trial design, including the...

06:00
YORBA LINDA, Calif., Sept. 24, 2018 /PRNewswire-PRWeb/ -- Starboard Medical Inc., a manufacturer of innovative and contemporary catheter securement devices for the acute care and home infusion markets, announced today that new research findings...

05:30
HLS Therapeutics Inc. ("HLS" or the "Company") announces that earlier today,...

05:00
NTC, une société pharmaceutique italienne, a présenté lors du congrès de la Société européenne des chirurgiens de la cataracte et la réfraction (European Society of Cataract & Refractive Surgeons ou ESCRS) à Vienne le protocole de Leader7, l'un des...

05:00
NTC, the Italian pharmaceutical company, presented at the ESCRS (European Society of Cataract & Refractive Surgeons) Congress of Vienna the protocol of Leader7, one of the largest clinical trials in ophthalmology at European level of the last decade....

01:36
New family of drug candidates inhibit the 'master switch' involved in inflammation and autoimmunity Able to cross the blood-brain barrier and blood-nerve barriers Opens development of treatments of inflammatory and autoimmune diseases of the brain...


23 septembre 2018

13:20
Abbott today announced positive clinical study results from a randomized controlled trial comparing treatment with the MitraClip® device to guideline-directed medical therapy in select patients with secondary (or functional) mitral regurgitation, or...


22 septembre 2018

13:35
Today, Boston Scientific announced positive 12-month data from the IMPERIAL trial, the first head-to-head drug-eluting stent trial in the superficial femoral artery (SFA). Results were presented during a late-breaking clinical trial session at the...


21 septembre 2018

18:00
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from a Phase 3 clinical study of the investigational product esketamine nasal spray in patients with treatment-resistant depression. Janssen researchers presented these...

10:32
SignalPath, a healthcare technology company developing innovative software tools that dramatically improve the ease and efficiency of trial execution and management, today announced the formation of the SignalPath Research Consortium. By partnering...

10:00
Astellas Pharma US, Inc. today announced the three C3 Prize Category Winners who will pitch their ideas for changing cancer care during a live pitch event at the Union for International Cancer Control (UICC) World Cancer Congress on October 3  in...

09:30
Cannabics Pharmaceuticals Inc. , a leader in personalized cannabinoid medicine focused on Cancer and its side effects, today announced that Dr. Gil Bar-Sela is scheduled to present his findings at the 3rd International Medical Cannabis...

08:00
Evofem Biosciences, Inc., ("Evofem" or the "Company"), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, announced today that...

08:00
MabVax Therapeutics Holdings, Inc. , a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the development of antibody-based products to address unmet medical needs, announces today that the Court of...

07:46
Eli Lilly and Company announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Emgalitytm (galcanezumab) for the prophylaxis of migraine in adults who have at...

07:27
AbbVie , a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion for VENCLYXTO® (venetoclax tablets) in...

07:24
Braeburn announces that Camurus has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the marketing authorization of CAM2038, an investigational buprenorphine flexible-dose...

07:00
Agenus Inc. , an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies1, today announced the closing of its non-dilutive royalty transaction with XOMA Corporation (XOMA), where XOMA...

03:07
- Latest clinical data builds on the wealth of evidence supporting the safety, efficacy and overall benefits of TECNIS Symfony® IOLs for cataract patients - Showcasing one of the latest solutions for patients with dry eye, LipiFlow® Thermal Pulsation...

00:00
Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical research data on cohort C at the 2018 Annual Meeting of Chinese Society of Clinical...


20 septembre 2018

22:45
Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data from a phase Ib clinical trial (NCT02937116) that treated patients with...

19:26
St. Jude Children's Research Hospital (St. Jude), the U.S. hospital leading the way...

18:44
Nearly 200 academic and industry researchers gathered this week to share updates on preclinical and clinical-stage Alzheimer's disease research at the 19th International Conference on Alzheimer's Drug Discovery. The two-day conference, organized by...

17:15
Cardiovalve announced today that it has commenced the AHEAD US multicenter study (U.S. Early Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System). AHEAD US...

14:54
Open Medicine Foundation (OMF), the premier nonprofit organization investing in research to cure myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), sponsors the Second Annual Community Symposium on the Molecular Basis of ME/CFS on September...

14:00
New drug discovery has been limited by researchers' inability to control a molecules' 3D structure. But a team of scientists from The Graduate Center of The City University of New York (GC/CUNY) has made a breakthrough in chemical synthesis that now...

13:15
AIVITA Biomedical announced today that it has dosed its first of 10 patients currently enrolled as part of its Phase 2 trial in patients with advanced ovarian cancer. The trial is designed to investigate AIVITA Biomedical's patient-specific cancer...

11:00
Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids. Published in the journal Cell Stem Cell the study is...

09:21
We live in an era of information overload, frequently confusing and contradictory.  The challenge and difficult task of evaluating and understanding available treatment options for prostate cancer is not immune to this quandary. ...

09:00
Researchers at the University of Illinois at Urbana?Champaign and Wolfram Research have developed a novel 3D-printing method called bioprinting that uses isomalt, a type of sugar found in throat lozenges, to generate physiological vasculature. The...

08:45
Enable Biosciences Inc. has been awarded a National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) Small Business Innovation Research (SBIR) Phase I grant for $223,806 to accelerate development of its minimally...

08:00
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has entered into a clinical trial collaboration agreement with a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A., known as MSD outside the United States and...

1 2 3 4 5 6 7 8 9 10